Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3053% below fair value
$43.64+0.61 (+1.42%)
Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –
Boston Scientific shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Boston Scientific's shares outstanding was 1.47B at Jun 30, 2026. For fiscal 2025 it was 1.49B, up 0.6% from the year before. Over ten years it grew 1.1% a year on average. The highest annual figure on record is 1.52B in fiscal 2011.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.49B | +0.6% |
| FY2024 | Dec 31, 2024 | 1.49B | +1.5% |
| FY2023 | Dec 31, 2023 | 1.46B | +1.7% |
| FY2022 | Dec 31, 2022 | 1.44B | +0.4% |
| FY2021 | Dec 31, 2021 | 1.43B | +1.2% |
| FY2020 | Dec 31, 2020 | 1.42B | +0.4% |
| FY2019 | Dec 31, 2019 | 1.41B | +0.7% |
| FY2018 | Dec 31, 2018 | 1.40B | +0.6% |
| FY2017 | Dec 31, 2017 | 1.39B | +1.1% |
| FY2016 | Dec 31, 2016 | 1.38B | +2.7% |
| FY2015 | Dec 31, 2015 | 1.34B | +1.3% |
| FY2014 | Dec 31, 2014 | 1.32B | -1.3% |
| FY2013 | Dec 31, 2013 | 1.34B | -4.7% |
| FY2012 | Dec 31, 2012 | 1.41B | -7.4% |
| FY2011 | Dec 31, 2011 | 1.52B | +0.1% |
| FY2010 | Dec 31, 2010 | 1.52B | +0.7% |
| FY2009 | Dec 31, 2009 | 1.51B | +0.6% |
| FY2008 | Dec 31, 2008 | 1.50B | +0.8% |
| FY2007 | Dec 31, 2007 | 1.49B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1.47B | -1.3% |
| Q1 FY2026 | Mar 31, 2026 | 1.50B | +0.1% |
| Q4 FY2025 | Dec 31, 2025 | 1.50B | +0.4% |
| Q3 FY2025 | Sep 30, 2025 | 1.50B | +0.5% |
| Q2 FY2025 | Jun 30, 2025 | 1.49B | +0.6% |
| Q1 FY2025 | Mar 31, 2025 | 1.49B | +0.8% |
| Q4 FY2024 | Dec 31, 2024 | 1.49B | +0.9% |
| Q3 FY2024 | Sep 30, 2024 | 1.49B | +0.8% |
| Q2 FY2024 | Jun 30, 2024 | 1.48B | +1.9% |
| Q1 FY2024 | Mar 31, 2024 | 1.48B | +2.5% |
| Q4 FY2023 | Dec 31, 2023 | 1.48B | +2.4% |
| Q3 FY2023 | Sep 30, 2023 | 1.48B | +2.4% |
| Q2 FY2023 | Jun 30, 2023 | 1.46B | +1.3% |
| Q1 FY2023 | Mar 31, 2023 | 1.45B | +0.5% |
| Q4 FY2022 | Dec 31, 2022 | 1.44B | +0.5% |
| Q3 FY2022 | Sep 30, 2022 | 1.44B | +0.3% |
| Q2 FY2022 | Jun 30, 2022 | 1.44B | +0.4% |
| Q1 FY2022 | Mar 31, 2022 | 1.44B | +0.5% |
| Q4 FY2021 | Dec 31, 2021 | 1.44B | +0.6% |
| Q3 FY2021 | Sep 30, 2021 | 1.44B | +0.3% |
| Q2 FY2021 | Jun 30, 2021 | 1.43B | +1.5% |
| Q1 FY2021 | Mar 31, 2021 | 1.43B | +1.2% |
| Q4 FY2020 | Dec 31, 2020 | 1.43B | +1.0% |
| Q3 FY2020 | Sep 30, 2020 | 1.43B | +1.3% |
| Q2 FY2020 | Jun 30, 2020 | 1.41B | +0.2% |
| Q1 FY2020 | Mar 31, 2020 | 1.41B | +0.4% |
| Q4 FY2019 | Dec 31, 2019 | 1.41B | +0.5% |
| Q3 FY2019 | Sep 30, 2019 | 1.41B | +0.6% |
| Q2 FY2019 | Jun 30, 2019 | 1.41B | +0.7% |
| Q1 FY2019 | Mar 31, 2019 | 1.41B | +0.8% |
| Q4 FY2018 | Dec 31, 2018 | 1.41B | +0.8% |
| Q3 FY2018 | Sep 30, 2018 | 1.40B | +0.7% |
| Q2 FY2018 | Jun 30, 2018 | 1.40B | +0.6% |
| Q1 FY2018 | Mar 31, 2018 | 1.40B | +0.5% |
| Q4 FY2017 | Dec 31, 2017 | 1.40B | +0.8% |
| Q3 FY2017 | Sep 30, 2017 | 1.39B | +1.0% |
| Q2 FY2017 | Jun 30, 2017 | 1.39B | – |
| Q1 FY2017 | Mar 31, 2017 | 1.39B | – |
| Q4 FY2016 | Dec 31, 2016 | 1.38B | – |
| Q3 FY2016 | Sep 30, 2016 | 1.38B | – |
See a number that looks wrong?